• Arismendi-Morillo GJ, Castellano-Ramirez AV. (2008) Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies. J Electron Microsc (Tokyo) 57:3339.
  • Greenspan RJ. (2001) The flexible genome. Nat Rev Genet 2:383387.
  • Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. (2008) Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 13 August [Epub ahead of print].
  • Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. (2002) Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 86:16151621.
  • Mukherjee P, Abate LE, Seyfried TN. (2004) Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 10:56225629.
  • Nebeling LC, Miraldi F, Shurin SB, Lerner E. (1995) Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 14:202208.
  • Potts R. (2002) Complexity of adaptibility in human evolution. In GoodmanM, MoffatAS (Eds) Probing human origins. American Academy of Arts & Sciences, Cambridge , Massachusetts , pp. 3357.
  • Seyfried TN, Sanderson TM, El-Abbadi MM, McGowan R, Mukherjee P. (2003) Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. Br J Cancer 89:13751382.
  • Seyfried TN, Mukherjee P. (2005a) Anti-angiogenic and pro-apoptotic effects of dietary restriction in experimental brain cancer: role of glucose and ketone bodies. In MeadowsGG (Ed) Integration/interaction of oncologic growth. Kluwer Academic, New York , pp. 258270.
  • Seyfried TN, Mukherjee P. (2005b) Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab (Lond) 2:30.
  • Sonnenschein C, Soto AM. (1999) The society of cells: cancer and the control of cell proliferation. Springer-Verlag, New York .
  • Strohman R. (2002) Maneuvering in the complex path from genotype to phenotype. Science 296:701703.
  • Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr. (2001) Ketone bodies, potential therapeutic uses. IUBMB Life 51:241247.
  • Veech RL. (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70:309319.
  • Warburg O. (1956) On the origin of cancer cells. Science 123:309314.
  • Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. (2007) The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 4:5.